Manager × security

Hood River Capital Management LLC VRNA holdings history

VERONA PHARMA PLC - ADR · CUSIP 925050106 · CIK 1578177

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2025-09-30, Hood River Capital Management LLC reported 18.88K VRNA (shares), valued at $2.01M, or 0.02% of its reported non-derivative portfolio. Filed 2025-11-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.02%
Shares
18.88K
18,882
Reported value
$2.01M
USD

Shares decreased 98.79%; reported value decreased 98.64%, and weight changed -2.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 2026Not reportedNot reported—
Q1 2026Not reportedNot reported—
Q4 2025Not reportedNot reported—
Q3 20250.02%18,882SEC filing ↗Filed Nov 14, 2025
Q2 20252.06%1,562,467SEC filing ↗Filed Aug 14, 2025
Q1 20251.66%1,532,348SEC filing ↗Filed May 15, 2025
Q4 20241.02%1,485,256SEC filing ↗Filed Feb 14, 2025
Q3 20240.67%1,433,934SEC filing ↗Filed Nov 14, 2024
Q2 20240.32%1,062,456SEC filing ↗Filed Aug 14, 2024
Q1 20240.35%987,756SEC filing ↗Filed May 15, 2024
Q4 20230.52%946,602SEC filing ↗Filed Feb 14, 2024
Q3 2023Not reportedNot reported—

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 2023Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q4 20230.52%946,602$18.82MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Feb 14, 2024
Q1 20240.35%987,756$15.89MShares increased 4.35%; reported value decreased 15.55%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20240.32%1,062,456$15.36MShares increased 7.56%; reported value decreased 3.33%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20240.67%1,433,934$41.25MShares increased 34.96%; reported value increased 168.53%, and weight changed +0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.02%1,485,256$68.98MShares increased 3.58%; reported value increased 67.20%, and weight changed +0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.66%1,532,348$97.29MShares increased 3.17%; reported value increased 41.05%, and weight changed +0.64 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20252.06%1,562,467$147.78MShares increased 1.97%; reported value increased 51.90%, and weight changed +0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20250.02%18,882$2.01MShares decreased 98.79%; reported value decreased 98.64%, and weight changed -2.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 2025Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q1 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q2 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Hood River Capital Management LLC · VERONA PHARMA PLC - ADR

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1578177","quarter":"2026Q2","cusip":"925050106"}

get_institutional_manager_history
{"cik":"1578177","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.